Gaudium IVF & Women Health Intrinsic Value

Gaudium IVF & Women Health (GAUDIUMIVF) median intrinsic value is ₹82.58 from 9 valuation models (range ₹30–₹186), vs current price ₹124.39 — -33.6% downside (Trading Above Calculated Value), margin of safety -50.6%. Also explore GAUDIUMIVF stock price history to track price trends across different timeframes.

Current Stock Price
₹124.39
Primary Intrinsic Value
₹134.64
Market Cap
₹385.6 Cr
-33.6% Downside
Median Value
₹82.58
Value Range
₹30 - ₹186
Assessment
Trading Above Calculated Value
Safety Margin
-50.6%

GAUDIUMIVF Valuation Methods Summary — DCF, Graham Number & P/E

Gaudium IVF & Women Health intrinsic value across 9 models vs current price ₹124.39 — upside/downside and value range per method. For current market price and key ratios, visit GAUDIUMIVF screener.

Method Type Intrinsic Value Range Upside/Downside Details
P/E Based Valuation earnings ₹134.64 ₹107.71 - ₹161.57 +8.2% EPS: ₹6.12, Sector P/E: 22x
Book Value Method asset ₹29.68 ₹26.71 - ₹32.65 -76.1% Book Value/Share: ₹14.84, P/B: 2.0x
Revenue Multiple Method revenue ₹82.58 ₹74.32 - ₹90.84 -33.6% Revenue/Share: ₹41.29, P/S: 2.0x
EBITDA Multiple Method earnings ₹180.65 ₹162.59 - ₹198.72 +45.2% EBITDA: ₹56.00Cr, EV/EBITDA: 10x
Simple DCF (5Y) dcf ₹49.76 ₹39.81 - ₹59.71 -60.0% CF Growth: 5.0%, Discount: 15%
PEG Ratio Method growth ₹39.17 ₹35.25 - ₹43.09 -68.5% EPS Growth: 8.0%, Fair P/E: 6.4x
Growth Adjusted P/E growth ₹94.55 ₹85.09 - ₹104.01 -24.0% Revenue Growth: 6.0%, Adj P/E: 15.5x
ROE Based Valuation profitability ₹185.81 ₹167.23 - ₹204.39 +49.4% ROE: 78.3%, P/E Multiple: 16x
Graham Defensive Method conservative ₹37.32 ₹33.59 - ₹41.05 -70.0% EPS: ₹6.12, BVPS: ₹14.84
Method Types: Earnings Asset DCF Growth Dividend Conservative

GAUDIUMIVF Intrinsic Value vs Market Price — All Valuation Models

Gaudium IVF & Women Health fair value range ₹30–₹186 vs current market price ₹124.39 across 9 valuation models. Browse GAUDIUMIVF balance sheet details for revenue, profit, balance sheet and cash flow data.

GAUDIUMIVF Intrinsic Value Analysis — Undervalued or Overvalued?

Gaudium IVF & Women Health median intrinsic value ₹82.58, current price ₹124.39 — Trading Above Calculated Value by 33.6%, margin of safety -50.6%.

What is the intrinsic value of GAUDIUMIVF?

Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Gaudium IVF & Women Health (GAUDIUMIVF) is ₹82.58 (median value). With the current market price of ₹124.39, this represents a -33.6% variance from our estimated fair value.

The valuation range spans from ₹29.68 to ₹185.81, indicating ₹29.68 - ₹185.81.

Is GAUDIUMIVF undervalued or overvalued?

Based on our multi-method analysis, Gaudium IVF & Women Health (GAUDIUMIVF) appears to be trading above calculated value by approximately 33.6%.

GAUDIUMIVF Financial Health — Key Ratios vs Industry Benchmarks

Gaudium IVF & Women Health financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Current Ratio 13.50 Industry Standard: 2.0+ Above 2.0 Measures short-term liquidity capacity
Return on Equity 78.3% Industry Standard: 15%+ Above 15% Measures shareholder return efficiency
Operating Margin 43.0% Industry Standard: 20%+ Above 20% Indicates operational efficiency level
Asset Turnover Ratio 1.44x Industry Standard: 1.0x+ Above 1.0x Measures asset utilization efficiency

GAUDIUMIVF Cash Flow Quality — Operating & Free Cash Flow

Gaudium IVF & Women Health operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2025 ₹9 Cr ₹2 Cr Positive Free Cash Flow 7/10
March 2024 ₹3 Cr ₹1 Cr Positive Free Cash Flow 7/10
March 2023 ₹24 Cr ₹16 Cr Positive Free Cash Flow 8/10
March 2022 ₹-1 Cr ₹-2 Cr Negative Cash Flow 3/10